PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

PharmaMedic Announces Expanded Medical Affairs Solutions to Boost Branded Sales from Existing Generic Portfolios 18 Jun 2026

With over 15 years of expertise in medical affairs and regulatory solutions, PharmaMedic has supported a broad range of clients, including generic manufacturers, in navigating complex market dynamics.  We emphasise practical, cost-effective strategies to maximize brand recognition, price positioning, and overall market impact through branding and strategic medical support.

PharmaMedic’s Managing Director states: “Many generic-focused teams face staffing constraints, tight budgets, and slim margins.  By partnering with PharmaMedic, companies can access an experienced, cost-efficient medical affairs function and marketing collaboration to elevate select products from their current portfolios into branded success stories.  Our successes with long-standing clients have seen improved brand and price recognition through strategic branding initiatives.”

The majority of our network of associates have held senior pharmaceutical positions, and we have helped to establish for many client companies, a high-end UK flexible medical function assisting in the launch and development of a large number of pharmaceutical and biotechnology products.

PMC’s services include:

– The setting up and maintaining of a flexible UK medical function for pharmaceutical companies involved at every stage of product development.

–  Working with marketing colleagues to brand generic products providing greater brand and price recognition.

–  Supporting venture capital and investment discussions and the review of product offerings.

–  Providing medical strategy and expertise in the licensing of a new medicine or indication.

–  Undertaking new product launches with our marketing partners.

–  Providing the review and “Certification” of materials in line with PMCPA Code requirements and a “water tight” and cost-effective process for their review.

– Liaising as an expert opinion and representative with Regulatory Authorities such as the MHRA and NHS payers, before and at product launch.

 

Discover how PharmaMedic can support your goals with a personalised, one-on-one session (in-person or virtual).  Reach out at hello@pharmamedic.co to book.

 

 

GeneralCategories

  • No categories

GeneralTags

#ABPI #BIA #cancer #ClinicalTrials #drugapprovals #drugdevelopment #drugregulation #EC #EFPIA #EMA #EU #HorizonEurope #HTA #innovation #lifesciences #marketaccess #medicalaffairs #medicalaffairsoutsourcing #medicaldevice #medicinesaccess #mentalhealth #mhra #NHS #NICE #patients #pharmaregulation #pre-eclampsia #R&D #rarediseases #regulation #regulatory #research #RWE #startups #UKgovernment #ukregulation #VPAS #WindsorFramework AI Biotech COVID-19 Healthcare Medical Affairs medicaldevices Pharma
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2026 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital